BAY-1895344 : Elimusertib, a Novel ATR Inhibitor, Induces Anti-Tumor Effects through Replication Catastrophe in Breast Cancers
Ralimetinib : c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer
BAY-1895344 : Elimusertib, a Novel ATR Inhibitor, Induces Anti-Tumor Effects through Replication Catastrophe in Breast Cancers
Ralimetinib : c-MYC Protein Stability Is Sustained by MAPKs in Colorectal Cancer